Kanda N, Tsuchida Y, Hata J, Kohl N E, Alt F W, Latt S A, Utakoji T
Cancer Res. 1987 Jun 15;47(12):3291-5.
Amplification of clones 8, G21, and N-myc, which were derived from human neuroblastoma cell lines IMR-32 and NB-19, were studied in nine neuroblastoma xenografts. N-myc was amplified from 50- to 120-fold in eight of nine xenografts, clone 8 was amplified in five of the xenografts, and clone G21 was amplified in four of these five. Each of these clones was localized by in situ hybridization to homogeneously staining regions in metaphase spreads of xenograft chromosomes. In one xenograft a DNA rearrangement of clone 8 was observed, and only two of the sequences detected by G21 were amplified. Restriction enzyme mapping indicated that the rearrangement within clone 8 occurred at a position close to the rearrangement previously noted in neuroblastoma cell line NB-9.
对源自人神经母细胞瘤细胞系IMR-32和NB-19的克隆8、G21和N-myc在9个神经母细胞瘤异种移植瘤中的扩增情况进行了研究。在9个异种移植瘤中的8个中,N-myc扩增了50至120倍,克隆8在5个异种移植瘤中扩增,克隆G21在这5个中的4个中扩增。通过原位杂交将这些克隆中的每一个定位到异种移植瘤染色体中期铺片中的均匀染色区。在一个异种移植瘤中观察到克隆8的DNA重排,并且G21检测到的序列中只有两个被扩增。限制性酶切图谱表明克隆8内的重排发生在与先前在神经母细胞瘤细胞系NB-9中发现的重排位置相近的位置。